The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
Abstract
To learn about the carboxy-terminal extent of amyloid beta-protein (A beta) composition of senile plaques (SPs) in the brain affected with Alzheimer's disease (AD), we employed two end-specific monoclonal antibodies as immunocytochemical probes: one is specific for A beta 40, the carboxyl terminus of A beta 1-40, while the other is specific for A beta 42(43). In the AD cortex, all SPs that were labeled with an authentic antibody were A beta 42(43) positive, while only one-third of which, on the average, were A beta 40 positive. There was a strong correlation between A beta 40 positivity and mature plaques. Two familial AD cortices with the mutation of beta-amyloid protein precursor 717 (beta APP717) (Val to Ile) showed a remarkable predominance of A beta 42(43)-positive, A beta 40-negative plaques. Diffuse plaques, representing the earliest stage of A beta deposition, were exclusively positive for A beta 42(43), but completely negative for A beta 40.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These observations indicate that Aps ending at Ap42(43), which are a minor component of the Ap in human cerebrospinal fluid and plasma, are critically important in AD where they deposit selectively in plaques of all kinds.”
From Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain (1995) · cites this paper as [21]
In the citing paper
“The immunocytochemical results shown here and in a recent report by Iwatsubo et al. (21) demonstrate that BC-05 intensely stains all types of senile plaques, that vessels are stained by both BC-OS and BA-27, and that BA-27 stains plaques poorly, in many cases only faintly staining occasional cored plaques (Fig. 3).”
From Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain (1995) · cites this paper as [21]
In the citing paper
“From studies of trisomy 21 brains (Iwatsubo et al., 1994), it is generally believed that, in human AD, A deposition begins with the formation of diffuse plaques.”
From Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (2001) · cites this paper as Iwatsubo et al., 1994
In the citing paper
“there is good evidence that A1-42 is deposited early and selectively in senile plaques (Iwatsubo et al., 1994).”
From Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (2001) · cites this paper as Iwatsubo et al., 1994
In the citing paper
“In contrast, Aβ40, the major Aβ peptide secreted by cells, appears to be the predominant species deposited in the amyloid deposits in the cerebral vasculature (congophillic angiopathy, CAA) (Gravina et al., 1995; Iwatsubo et al., 1994).”
From Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice (2005) · cites this paper as Iwatsubo et al., 1994
In the citing paper
“These data provide definitive in vivo confirmation of predictions inferred from (1) in vitro studies of Aβ aggregation, (2) effects of PS and certain APP mutations on Aβ production and deposition, and (3) analyses of Aβ peptides in the human AD brain (Gravina et al., 1995; Iwatsubo et al., 1994).”
From Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice (2005) · cites this paper as Iwatsubo et al., 1994
In the citing paper
“Indeed, Aβ42 is the main component of amyloid plaques and is shown to be neurotoxic [30].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [30]
In the citing paper
“the slightly longer Aβ42 species that is specifically linked with FAD is also the first Aβ species deposited in cerebral plaques [82].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [82]
In the citing paper
“The subsequent development of antibodies directed at the free C-terminal ends of Aβ40 or Aβ42 [82] led to the ability to differentiate Aβ from APP labeling”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [82]
Citations
Cites
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Cited by
Sorted by citations
Items 501–600 of 1,000
Clusterin levels are increased in A lzheimer's disease and influence the regional distribution of Aβ
Miners, J. S., Clarke, P., & Love, S. (2016) · Brain Pathology · doi:10.1111/bpa.12392 · Cited by 83
Alzheimer Aβ neurotoxicity: Promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides
Ma, J., Brewer, H. B., & Potter, H. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00112-1 · Cited by 108
Fan, D., Liu, L., Wu, Z., & Cao, M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180419141613 · Cited by 80
Key Residue for Aggregation of Amyloid-β Peptides
Itoh, S., Yagi‐Utsumi, M., Kato, K., & Okumura, H. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00358 · Cited by 81
Cerebellar diffuse amyloid plaques are derived from dendritic Aβ42 accumulations in Purkinje cells
Wang, H.-Y., D’Andrea, M. R., & Nagele, R. G. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00279-2 · Cited by 80
Kida, E., Choi-Miura, N.-H., & Wisniewski, K. E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00482-6 · Cited by 79
Alzheimer dementia caused by a novel mutation located in the APP C-terminal intracytosolic fragment
Theuns, J., Marjaux, E., Vandenbulcke, M., Laere, K. V., Kumar‐Singh, S., Bormans, G. M., Brouwers, N., den Broeck, M. V., Vennekens, K. M., Corsmit, E., et al. (2006) · Human Mutation · doi:10.1002/humu.20402 · Cited by 82
Hashimoto, M., Shahdat, H. M., Yamashita, S., Katakura, M., Tanabe, Y., Fujiwara, H., Gamoh, S., Miyazawa, T., Arai, H., Shimada, T., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05731.x · Cited by 80
Lee, E. B., Skovronsky, D., Abtahian, F., Doms, R. W., & Lee, V. M. ‐. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210105200 · Cited by 78
Morinaga, A., Hasegawa, K., Nomura, R., Ookoshi, T., Ozawa, D., Goto, Y., Yamada, M., & Naiki, H. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.01.012 · Cited by 82
Collins-Praino, L. E., Francis, Y. I., Griffith, E. Y., Wiegman, A. F., Urbach, J., Lawton, A., Honig, L. S., Cortes, E., Vonsattel, J. P. G., Canoll, P. D., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0083-0 · Cited by 79
Aleksis, R., Oleskovs, F., Jaudzems, K., Pahnke, J., & Biverstål, H. (2017) · Biochimie · doi:10.1016/j.biochi.2017.07.011 · Cited by 80
Preclinical validation of a potent γ-secretase modulator for Alzheimer’s disease prevention
Rynearson, K. D., Ponnusamy, M., Prikhodko, O., Xie, Y., Zhang, C., Nguyen, P., Hug, B., Sawa, M., Becker, A., Spencer, B., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20202560 · Cited by 76
Voorhees, J. R., Remy, M. T., Cintrón-Pérez, C. J., El Rassi, E., Khan, M. Z., Dutca, L. M., Yin, T. C., McDaniel, L. N., Williams, N. S., Brat, D. J., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.023 · Cited by 78
Singhrao, S., Thomas, P., Wood, J. D., Macmillan, J., Neal, J. W., Harper, P. S., & Jones, A. L. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6778 · Cited by 81
Radioiodinated Flavones for in Vivo Imaging of β-Amyloid Plaques in the Brain
Ono, M., Yoshida, N., Ishibashi, K., Haratake, M., Arano, Y., Mori, H., & Nakayama, M. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050635e · Cited by 78
Sato, N., & Morishita, R. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00143 · Cited by 84
Cu(II) interaction with N-terminal fragments of human and mouse β-amyloid peptide
Kowalik‐Jankowska, T. (2001) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(01)00226-4 · Cited by 78
Tomita, T., Tokuhiro, S., Hashimoto, T., Aiba, K., Saido, T. C., Maruyama, K., & Iwatsubo, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.21153 · Cited by 78
Self-citationNishiyama, K., Trapp, B. D., Ikezu, T., Ransohoff, R. M., Tomita, T., Iwatsubo, T., Kanazawa, I., Hsiao, K., Lisanti, M. P., & Okamoto, T. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06538.1999 · Cited by 78
Self-citationA Luminex Assay Detects Amyloid β Oligomers in Alzheimer’s Disease Cerebrospinal Fluid
Herskovits, A. Z., Locascio, J. J., Peskind, E. R., Li, G., & Hyman, B. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067898 · Cited by 77
Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?
Hunter, S., & Brayne, C. (2017) · Journal of Negative Results in BioMedicine · doi:10.1186/s12952-017-0066-3 · Cited by 80
Wittnam, J. L., Portelius, E., Zetterberg, H., Gustavsson, M. K., Schilling, S., Koch, B. C. P., Demuth, H., Blennow, K., Wirths, O., & Bayer, T. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.308601 · Cited by 77
Glycation and Microglial Reaction in Lesions of Alzheimer's Disease
Dickson, D. W., Sinicropi, S., Yen, S.-H. C., Ko, L., Mattiace, L. A., Bucala, R., & Vlassara, H. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00116-9 · Cited by 76
Single cell gene expression profiling in Alzheimer’s disease
Ginsberg, S. D., Che, S., Counts, S., & Mufson, E. J. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.05.007 · Cited by 76
Schilling, S., Appl, T., Hoffmann, T., Cynis, H., Schulz, K., Jagla, W., Friedrich, D., Wermann, M., Buchholz, M., Heiser, U. F., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05471.x · Cited by 77
Death and survival of neuronal cells exposed to Alzheimer's insults
Niikura, T., Hashimoto, Y., Tajima, H., & Nishimoto, I. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10354 · Cited by 78
Interleukin-6, β-amyloid peptide and NMDA interactions in rat cortical neurons
Qiu, Z., & Gruol, D. L. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00158-9 · Cited by 79
Sasahara, K., Morigaki, K., & Shinya, K. (2013) · Physical Chemistry Chemical Physics · doi:10.1039/c3cp44517h · Cited by 75
Seed-induced acceleration of amyloid-β mediated neurotoxicity in vivo
Sowade, R. F., & Jahn, T. R. (2017) · Nature Communications · doi:10.1038/s41467-017-00579-4 · Cited by 78
Molecular Insights into Human Serum Albumin as a Receptor of Amyloid-β in the Extracellular Region
Choi, T. S., Lee, H. J., Han, J. Y., Lim, M. H., & Kim, H. I. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b08584 · Cited by 76
β-Amyloid Protein Structure Determines the Nature of Cytokine Release From Rat Microglia
Lindberg, C., Selenica, M. B., Westlind‐Danielsson, A., & Schultzberg, M. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:1:001 · Cited by 76
Amyloid probes based on Congo Red distinguish between fibrils comprising different peptides.
Ashburn, T. T., Han, H., Mcguinness, B., & Lansbury, P. (1996) · Chemistry and Biology · doi:10.1016/s1074-5521(96)90118-0 · Cited by 70
A novel presenilin‐1 mutation: Increased β‐amyloid and neurofibrillary changes
Gómez‐Isla, T., Wasco, W., Pettingell, W. P., Gurubhagavatula, S., Schmidt, S. D., Jondro, P. D., McNamara, M. J., Rodes, L., Di-Blasi, T., Growdon, W. B., et al. (1997) · Annals of Neurology · doi:10.1002/ana.410410618 · Cited by 77
Akiyama, H., Schwab, C., Kondo, H., Mori, H., Kametani, F., Ikeda, K., & McGeer, P. L. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)12474-5 · Cited by 76
A Distinct ER/IC γ-Secretase Competes with the Proteasome for Cleavage of APP
Skovronsky, D., Pijak, D. S., Doms, R. W., & Lee, V. M. ‐. (1999) · Biochemistry · doi:10.1021/bi991728z · Cited by 76
Rogers, K., Felsenstein, K. M., Hrdlicka, L., Tu, Z., Albayya, F., Lee, W., Hopp, S., Miller, M.-J., Spaulding, D., Yang, Z., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-61 · Cited by 75
Das, R. C., Rauf, A., Akhter, S., Islam, M. N., Emran, T. B., Mitra, S., Khan, I. N., & Mubarak, M. S. (2021) · Molecules · doi:10.3390/molecules26123696 · Cited by 79
Ogi, H. (2013) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.89.401 · Cited by 78
Liu, K., Guo, T. L., Chojnacki, J. E., Lee, H., Wang, X., Siedlak, S. L., Rao, W., Zhu, X., & Zhang, S. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200122j · Cited by 75
Wang, X., Zeng, J., Feng, J., Tian, Y., Liu, Y., Qiu, M., Xiong, Y., Yang, Y., Xiong, Y., Zhang, Z., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00066 · Cited by 77
Vashist, S., Cushman-Nick, M., & Shorter, J. (2010) · Biochemistry and Cell Biology · doi:10.1139/o09-121 · Cited by 76
Cacquevel, M., Aeschbach, L., Houacine, J., & Fraering, P. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035133 · Cited by 75
Tam, J. H. K., Seah, C., & Pasternak, S. (2014) · Molecular Brain · doi:10.1186/s13041-014-0054-1 · Cited by 83
Chen, S., Zhang, B., Wang, Y., Li, H., Xiong, R., Zhao, Z., Chu, X., Li, Q., & Sun, S. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s99958 · Cited by 75
Update on Biomarkers For Amyloid Pathology in Alzheimer’s Disease
Ashton, N. J., Schöll, M., Heurling, K., Gkanatsiou, E., Portelius, E., Höglund, K., Brinkmalm, G., Hye, A., Blennow, K., & Zetterberg, H. (2018) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0433 · Cited by 78
Michno, W., Nyström, S., Wehrli, P. M., Lashley, T., Brinkmalm, G., Guérard, L., Syvänen, S., Sehlin, D., Kaya, I., Brinet, D., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006604 · Cited by 75
Morgan, T. E., Laping, N. J., Rozovsky, I., Oda, T., Hogan, T. H., Finch, C. E., & Pasinetti, G. M. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00194-s · Cited by 75
Saura, C. A., Tomita, T., Davenport, F., Harris, C. L., Iwatsubo, T., & Thinakaran, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13818 · Cited by 75
Self-citationBrain Trauma in Aged Transgenic Mice Induces Regression of Established Aβ Deposits
Nakagawa, Y., Reed, L., Nakamura, M., McIntosh, T. K., Smith, D. H., Saatman, K. E., Raghupathi, R., Clemens, J., Saido, T. C., Lee, V. M.-Y., et al. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7375 · Cited by 91
Head, E., Doran, E. W., Nistor, M., HILL, M., Schmitt, F. A., Haier, R. J., & Lott, I. T. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101335 · Cited by 75
Aspects of β-Amyloid as a Biomarker for Alzheimer's Disease
Andréasson, U., Portelius, E., Andersson, M. E., Blennow, K., & Zetterberg, H. (2007) · Biomarkers in Medicine · doi:10.2217/17520363.1.1.59 · Cited by 74
Mavroudis, I. A., Fotiou, D. F., Adipepe, L. F., Manani, M. G., Njau, S. N., Psaroulis, D., Costa, V., & Balogiannis, S. (2010) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317510382892 · Cited by 74
Maddalena, A. S., Papassotiropoulos, A., Gonzalez-Agosti, C., Signorell, A., Hegi, T., Pasch, T., Nitsch, R. M., & Höck, C. (2004) · Neurodegenerative Diseases · doi:10.1159/000080991 · Cited by 75
Insulin resistance, neuroinflammation, and Alzheimer’s disease
Najem, D., Bamji‐Mirza, M., Chang, N., Liu, Q. Y., & Zhang, W. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0050 · Cited by 76
Allosteric regulation of γ-secretase activity by a phenylimidazole-type γ-secretase modulator
Takeo, K., Tanimura, S., Shinoda, T., Osawa, S., Zahariev, I. K., Takegami, N., Ishizuka‐Katsura, Y., Shinya, N., Takagi‐Niidome, S., Tominaga, A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402171111 · Cited by 74
Self-citationβ-Amyloid Production, Aggregation, and Clearance as Targets for Therapy in Alzheimer's Disease
Felice, F. G. D., & Ferreira, S. T. (2002) · Cellular and Molecular Neurobiology · doi:10.1023/a:1021832302524 · Cited by 75
Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features
Giaccone, G., Morbin, M., Moda, F., Botta, M., Mazzoleni, G., Uggetti, A., Catania, M., Moro, M. L., Redaelli, V., Spagnoli, A., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0747-1 · Cited by 73
Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease
Prvulovic, D., & Hampel, H. J. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.087 · Cited by 76
Yu, Y., Zhang, L., Li, C., Sun, X., Tang, D., & Shi, G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201405001 · Cited by 74
Structural Insights into Aβ42 Oligomers Using Site-directed Spin Labeling
Gu, L., Liu, C., & Guo, Z. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.457739 · Cited by 75
Wild-type Presenilin 1 Protects against Alzheimer Disease Mutation-induced Amyloid Pathology
Wang, R., Wang, B., He, W., & Zheng, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512574200 · Cited by 75
Rygiel, K. (2016) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.194867 · Cited by 76
Mann, D. M. A., Davidson, Y. S., Robinson, A. C., Allen, N., Hashimoto, T., Richardson, A., Jones, M., Snowden, J. S., Pendleton, N., Potier, M.-C., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1866-3 · Cited by 73
Self-citationModulation of Disordered Proteins with a Focus on Neurodegenerative Diseases and Other Pathologies
Martinelli, A. H. S., Lopes, F. C., John, E. B. D. O., Carlini, C. R., & Ligabue‐Braun, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061322 · Cited by 99
Structural mechanism for specific binding of chemical compounds to amyloid fibrils
Tao, Y., Xia, W., Zhao, Q., Xiang, H., Han, C., Zhang, S., Gu, W., Tang, W., Li, Y., Tan, L., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01370-x · Cited by 74
Yamakawa, M. Y., Uchino, K., Watanabe, Y., Adachi, T., Nakanishi, M., Ichino, H., Hongo, K., Mizobata, T., Kobayashi, S., Nakashima, K., et al. (2015) · Nutritional Neuroscience · doi:10.1179/1476830515y.0000000042 · Cited by 75
Cotton Wool Plaques in Non-Familial Late-Onset Alzheimer Disease
Le, T. V., Crook, R., Hardy, J., & Dickson, D. W. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.11.1051 · Cited by 72
Tamaoka, A., Sawamura, N., Odaka, A., Suzuki, N., Mizusawa, H., Shoji, S., & Mori, H. (1995) · Brain Research · doi:10.1016/0006-8993(95)00162-j · Cited by 72
Self-citationChang, K., & Suh, Y. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.cr0050014 · Cited by 72
Nishitsuji, K., Hosono, T., Uchimura, K., & Michikawa, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.172106 · Cited by 65
Hashimoto, T., Adams, K. W., Fan, Z., McLean, P. J., & Hyman, B. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257378 · Cited by 71
Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy
Banerjee, G., Ambler, G., Keshavan, A., Paterson, R. W., Foiani, M. S., Toombs, J., Heslegrave, A., Dickson, J. C., Fraioli, F., Groves, A. M., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191254 · Cited by 74
Schmidt, M. L., Robinson, K. A., Lee, V. M., & Trojanowski, J. Q. (1995) · Europe PMC (PubMed Central) · Cited by 71
Yagishita, S., Morishima‐Kawashima, M., Tanimura, Y., Ishiura, S., & Ihara, Y. (2006) · Biochemistry · doi:10.1021/bi0521846 · Cited by 71
Self-citationGrandjean, J., Schroeter, A., He, P., Tanadini, M., Keist, R., Krstic, D., Konietzko, U., Klohs, J., Nitsch, R. M., & Rudin, M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4762-13.2014 · Cited by 70
“The occurrence of amyloid plaques in brain parenchyma and around the cerebral vessels constitutes a hallmark of Alzheimer’s disease (AD; Iwatsubo et al., 1994).”
BackgroundAnimal models of cerebral amyloid angiopathy
Jäkel, L., Nostrand, W. E. V., Nicoll, J. A. R., Werring, D. J., & Verbeek, M. M. (2017) · Clinical Science · doi:10.1042/cs20170033 · Cited by 71
Schmechel, A., Zentgraf, H., Scheuermann, S., Fritz, G., Pipkorn, R., Reed, J., Beyreuther, K. T., Bayer, T. A., & Multhaup, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303547200 · Cited by 69
Tsuzuki, K., Fukatsu, R., Yamaguchi, H., Tateno, M., Imai, K., Fujii, N., & Yamauchi, T. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00834-x · Cited by 72
Mikulca, J. A., Nguyen, V., Gajdosik, D. A., Teklu, S. G., Giunta, E. A., Lessa, E. A., Tran, C. H., Terak, E. C., & Raffa, R. B. (2013) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12112 · Cited by 70
Kawasumi, M., Chiba, T., Yamada, M., Miyamae‐Kaneko, M., Matsuoka, M., Nakahara, J., Tomita, T., Iwatsubo, T., Kato, S., Aiso, S., et al. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03397.x · Cited by 68
Self-citationThe Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
Matton, A., Welander, H., Winblad, B. G., Graff, C., & Tjernberg, L. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055847 · Cited by 69
do Nascimento, K. K. F., Silva, K. P., Malloy‐Diniz, L. F., Butters, M. A., & Diniz, B. S. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.07.024 · Cited by 72
Quantitative analysis of co-oligomer formation by amyloid-beta peptide isoforms.
Iljina, M., Garcia, G. A., Dear, A. J., Flint, J., Narayan, P., Michaels, T. C. T., Dobson, C. M., Frenkel, D., Knowles, T. P. J., & Klenerman, D. (2016) · Scientific Reports · doi:10.1038/srep28658 · Cited by 68
Chun, Y. S., Park, Y., Oh, H. G., Kim, T., Yang, H. O., Park, M. K., & Chung, S. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-140096 · Cited by 68
Hossain, S., Hashimoto, M., Katakura, M., Miwa, K., Shimada, T., & Shido, O. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06336.x · Cited by 70
Sanchez-Espinosa, M. P., Atienza, M., & Cantero, J. L. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.05.027 · Cited by 70
Human apolipoprotein E4 accelerates β‐amyloid deposition in APPsw transgenic mouse brain
Carter, D. B., Dunn, E., McKinley, D. D., Stratman, N. C., Boyle, T. P., Kuiper, S. L., Oostveen, J. A., Weaver, R. J., Boller, J. A., & Gurney, M. E. (2001) · Annals of Neurology · doi:10.1002/ana.1134 · Cited by 70
Protein aggregates and dementia: is there a common toxicity?
Lovestone, S. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.152 · Cited by 69
Del Amo, L., Cano, A., Ettcheto, M., Souto, E. B., Espina, M., Camins, A., García, M. L., & Sánchez-López, E. (2021) · Applied Sciences · doi:10.3390/app11094305 · Cited by 67
Currò, M., Risitano, R., Ferlazzo, N., Cirmi, S., Gangemi, C. M. A., Caccamo, D., Ientile, R., & Navarra, M. (2016) · Scientific Reports · doi:10.1038/srep20809 · Cited by 68
Takata, K., Amamiya, T., Mizoguchi, H., Kawanishi, S., Kuroda, E., Kitamura, R., Ito, A., Saito, Y., Tawa, M., Nagasawa, T., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.021 · Cited by 68
Progress toward valid transgenic mouse models for Alzheimer’s disease
Guénette, S. Y., & Tanzi, R. E. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00042-1 · Cited by 67
Su, J. H., Cummings, B. J., & Cotman, C. W. (1998) · Acta Neuropathologica · doi:10.1007/s004010050920 · Cited by 67
Sohma, Y., & Kiso, Y. (2006) · ChemBioChem · doi:10.1002/cbic.200600112 · Cited by 70
Accumulation of β-Amyloid fibrils in pancreas of transgenic mice
Kawarabayashi, T., Shoji, M., Sato, M., Sasaki, A., Ho, L., Eckman, C. B., Prada, C.-M., Younkin, S. G., Kobayashi, T., Tada, N., et al. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02061-6 · Cited by 66
Devkota, S., Williams, T. D., & Wolfe, M. S. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100281 · Cited by 65
Aβ42 gene vaccination reduces brain amyloid plaque burden in transgenic mice
Qu, B., Boyer, P. J., Johnston, S. A., Hynan, L. S., & Rosenberg, R. N. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.02.006 · Cited by 67
Amyloid β 1-42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs
Wısnıewskı, T., Lalowski, M. M., Bobik, M., RUSSELL, M., Strosznajder, J. B., & Frangione, B. (1996) · Biochemical Journal · doi:10.1042/bj3130575 · Cited by 66
Murine Aβ over-production produces diffuse and compact Alzheimer-type amyloid deposits
Xu, G., Ran, Y., Fromholt, S. E., Fu, C., Yachnis, A. T., Golde, T. E., & Borchelt, D. R. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0252-9 · Cited by 65
Metadata
- Authors
- Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y.
- Affiliations
- Takeda (Japan) (JP)
- The University of Tokyo (JP)
- University of Tsukuba (JP)
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 1994-07
- Volume
- 13
- Issue
- 1
- Pages
- 45-53
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W1991435932
- Cited by
- 1,774
- References
- 41
- Citations by year
- 2026: 30 · 2025: 41 · 2024: 53 · 2023: 49 · 2022: 49 · 2021: 55 · 2020: 68 · 2019: 49 · 2018: 41 · 2017: 49 · 2016: 52 · 2015: 45 · 2014: 68 · 2013: 69 · 2012: 66
- FWCI
- 35.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, Aβ40, amyloid plaques, Alzheimer's disease, familial Alzheimer's disease, plaque maturation, diffuse plaques, immunocytochemistry
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Antibodies, Monoclonal, Brain, Cerebral Cortex, Female, Humans, Immunoenzyme Techniques, Male, Middle Aged, Mutation, Peptide Fragments, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
